Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy F Ding, X Gao, X Huang, H Ge, M Xie, J Qian, J Song, Y Li, X Zhu, ... Biomaterials 245, 119976, 2020 | 208 | 2020 |
The landscape of mRNA nanomedicine X Huang, N Kong, X Zhang, Y Cao, R Langer, W Tao Nature Medicine 28 (11), 2273-2287, 2022 | 207 | 2022 |
Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy C Liu, S Sun, Q Feng, G Wu, Y Wu, N Kong, Z Yu, J Yao, X Zhang, ... Advanced Materials 33 (37), 2102054, 2021 | 122 | 2021 |
mRNA-based cancer therapeutics C Liu, Q Shi, X Huang, S Koo, N Kong, W Tao Nature Reviews Cancer 23 (8), 526-543, 2023 | 113 | 2023 |
Well-defined multivalent ligands for hepatocytes targeting via asialoglycoprotein receptor X Huang, JC Leroux, B Castagner Bioconjugate chemistry 28 (2), 283-295, 2017 | 111 | 2017 |
Emerging mRNA technologies: delivery strategies and biomedical applications Y Xiao#, Z Tang#, X Huang#, W Chen, J Zhou, H Liu, C Liu, N Kong, ... Chemical Society Reviews, 2022 | 108 | 2022 |
Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy Y Zou, X Sun, Q Yang, M Zheng, O Shimoni, W Ruan, Y Wang, D Zhang, ... Science advances 8 (16), eabm8011, 2022 | 102 | 2022 |
Nanotechnology-based strategies against SARS-CoV-2 variants X Huang, E Kon, X Han, X Zhang, N Kong, MJ Mitchell, D Peer, W Tao Nature Nanotechnology 17 (10), 1027-1037, 2022 | 79 | 2022 |
A non-cationic nucleic acid nanogel for the delivery of the CRISPR/Cas9 gene editing tool F Ding, X Huang, X Gao, M Xie, G Pan, Q Li, J Song, X Zhu, C Zhang Nanoscale 11 (37), 17211-17215, 2019 | 75 | 2019 |
Triple-stimuli (pH/thermo/reduction) sensitive copolymers for intracellular drug delivery X Huang, X Jiang, Q Yang, Y Chu, G Zhang, B Yang, R Zhuo Journal of Materials Chemistry B 1 (13), 1860-1868, 2013 | 66 | 2013 |
Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages X Huang, C Liu, N Kong, Y Xiao, A Yurdagul Jr, I Tabas, W Tao Nature protocols 17 (3), 748-780, 2022 | 59 | 2022 |
Nanoscale materials-based platforms for the treatment of bone-related diseases X Zhang#, S Koo#, JH Kim#, X Huang#, N Kong, L Zhang, J Zhou, J Xue, ... Matter 4 (9), 2727-2764, 2021 | 57 | 2021 |
Characterization of calcium phosphate nanoparticles based on a PEGylated chelator for gene delivery X Huang, D Andina, J Ge, A Labarre, JC Leroux, B Castagner ACS applied materials & interfaces 9 (12), 10435-10445, 2017 | 47 | 2017 |
pH-responsive and gemcitabine-containing DNA nanogel to facilitate the chemodrug delivery G Pan, Q Mou, Y Ma, F Ding, J Zhang, Y Guo, X Huang, Q Li, X Zhu, ... ACS applied materials & interfaces 11 (44), 41082-41090, 2019 | 46 | 2019 |
Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy Z Tang, Y Xiao, N Kong, C Liu, W Chen, X Huang, D Xu, J Ouyang, ... Acta Pharmaceutica Sinica B 11 (11), 3447-3464, 2021 | 41 | 2021 |
Oral drug delivery platforms for biomedical applications J Ouyang, Z Zhang, B Deng, J Liu, L Wang, H Liu, S Koo, S Chen, Y Li, ... Materials Today 62, 296-326, 2023 | 39 | 2023 |
RNA cancer nanomedicine: nanotechnology-mediated RNA therapy BE Ferdows, DN Patel, W Chen, X Huang, N Kong, W Tao Nanoscale 14 (12), 4448-4455, 2022 | 39 | 2022 |
Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes Y Xiao, Z Tang, X Huang, J Joseph, W Chen, C Liu, J Zhou, N Kong, ... Matter 4 (10), 3269-3285, 2021 | 39 | 2021 |
Intercalation-driven formation of siRNA nanogels for cancer therapy X Huang, G Wu, C Liu, X Hua, Z Tang, Y Xiao, W Chen, J Zhou, N Kong, ... Nano Letters 21 (22), 9706-9714, 2021 | 37 | 2021 |
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy X Huang, NT Blum, J Lin, J Shi, C Zhang, P Huang Materials horizons 8 (1), 78-101, 2021 | 36 | 2021 |